Kenneth Barber v. HHS - Tdap, Guillain-Barré syndrome (2021)

On April 24, 2019, Kenneth Barber filed a petition for compensation alleging that the tetanus-diphtheria-acellular pertussis (Tdap) and pneumococcal conjugate (PCV) vaccines he received on February 21, 2018, caused him to suffer Guillain-Barré syndrome (GBS) and its residual effects for more than six months. The vaccines are listed on the Vaccine Injury Table.

The respondent denied that the vaccines caused Mr. Barber's GBS or any other injury.

However, the parties filed a joint stipulation agreeing to compensation. Special Master Christian J.

Moran reviewed the stipulation and adopted it as the decision of the Court. The stipulation awarded Mr.

Barber a lump sum payment of $62,500.00, payable by check to the petitioner, as compensation for all damages. The decision was filed on May 25, 2021.

Petitioner counsel was Diana L. Stadelnikas of Maglio Christopher and Toale, PA, and respondent counsel was Jennifer L.

Reynaud of the United States Department of Justice. The public decision does not describe the onset of symptoms, specific clinical details, or expert testimony.